Do selective serotonin reuptake inhibitors cause suicide?: Discrediting old drugs may be useful in marketing new ones

doi:10.1136/bmj.330.7500.1149

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Hugh M Jones, consultant psychiatrist (hugh.jones@slam.nhs.uk)

Lordship Lane Community Mental Health Team, London SE22 8HN

EDITOR—Fergusson et al report the association between suicide attempts and use of selective serotonin reuptake inhibitors (SSRIs).1 A causal link between use of an SSRI and self harm would have drastic clinical implications for health services. The extra monitoring might make using antidepressants wholly impractical in a risk averse service.

The reported incidence …